RxDoctor Payments Data

Jonathan Clapp, MD

Physical Medicine & Rehabilitation · Englewood, CONPI 1811153224

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 28.4% of the total.

$748in general payments, 2019–2025

Across 7 payments — averaging $106.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$213
  • MML US, Inc.$164
  • Abbott$140
  • Avanos Medical$132
  • Boston Scientific$71
  • Collegium Pharmaceutical, Inc.$15
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$748100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$748 in reported general payments places this provider in the 70th percentile of 199 physical medicine & rehabilitation providers in Colorado.

See all physical medicine & rehabilitation providers in Colorado

Medicare billing

Part B allowed, 2024
$320,149
Medicare patients
679
Services billed
2,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl30$15,195
Naloxone Hcl119$7,587
Methocarbamol184$1,108
Oxycodone Hcl138$1,018
Dexamethasone96$621
Tramadol Hcl65$443
Hydromorphone Hcl48$330
Celecoxib22$298
Lidocaine12$227
Morphine Sulfate14$210
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$138
Ondansetron Hcl57$110
Pantoprazole Sodium19$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta$15$15,19530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 199 physical medicine & rehabilitation providers in Colorado.

Other physical medicine & rehabilitation in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →